Ultrasound Devices Market Size & Growth Forecast 2026–2035, By Segments (Product, End-use, Portability, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Ultrasound Devices Market size was estimated at USD 10.5 Billion in 2025 and is projected to grow at a 4.4% CAGR from 2026 to 2035, exceeding USD 16.15 Billion by 2035. The industry revenue for 2026 is calculated at USD 10.9 billion.

• Base Year Value (2025): USD 10.5 Billion
• CAGR (2026-2035): 4.4%
• Forecast Year Value (2035): USD 16.15 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Ultrasound Devices Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America leads through mature diagnostic imaging infrastructure, broad deployment across healthcare settings, and steady replacement demand for advanced and portable ultrasound systems used in routine care.
  • Asia Pacific is expected to grow at a 5.02% CAGR as healthcare providers expand diagnostic capacity, increase equipment adoption, and invest in hospitals, clinics, and diagnostic centers.

• Segment Momentum:

  • Diagnostic Ultrasound Devices held an 80.06% share in 2025 due to their essential role in routine imaging, providing real-time, non-invasive visualization across multiple clinical specialties and care settings.
  • Hospitals held a 42.88% share in 2025 and remain the fastest-growing end users as they expand imaging, emergency, point-of-care, and procedural ultrasound services within integrated clinical workflows.

• Market Expansion Drivers:

  • Increasing chronic disease burden driving demand for non-invasive diagnostic ultrasound imaging systems.
  • Advancements in AI-enabled and 3D ultrasound technologies enhancing imaging workflow efficiency.
  • Rising adoption of portable and wireless ultrasound devices expanding point-of-care diagnostics accessibility.

• Leading Market Participants:

  Leading players in the ultrasound devices market include GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Canon Medical Systems Corporation (Japan), Samsung Medison Co., Ltd. (South Korea), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), FUJIFILM SonoSite, Inc. (United States), Esaote S.p.A. (Italy), Konica Minolta, Inc. (Japan), Hitachi, Ltd. (Japan).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 10.5 Billion
  • Projected Market Size: USD 16.15 Billion by 2035
  • Growth Forecasts: 4.4% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Diagnostic Ultrasound Devices (Product) | Hospitals (End-use) | Cart/Trolley (Portability) | Radiology (Application)
  • Emerging Opportunity Segment: Therapeutic Ultrasound Devices (Product) | Hospitals (End-use) | Handheld (Portability) | Obstetrics/Gynaecology (Application)

Market Growth Drivers and Industry Trends

Increasing chronic disease burden driving demand for non-invasive diagnostic ultrasound imaging systems

As chronic conditions such as cardiovascular disorders, liver disease, kidney complications, and cancer require repeated imaging for diagnosis, monitoring, and treatment planning, providers increasingly favor modalities that can be used frequently without radiation exposure or complex patient preparation. This dynamic is driving demand for the ultrasound devices market because ultrasound systems fit routine follow-up workflows in outpatient clinics, emergency departments, and specialty practices where fast, non-invasive assessment is essential. Hospitals and diagnostic centers respond by expanding installed capacity, upgrading system capability for higher-resolution and specialty imaging, and integrating ultrasound more deeply into chronic care pathways, reinforcing market demand through recurring clinical use rather than one-time equipment purchases.

Advancements in AI-enabled and 3D ultrasound technologies enhancing imaging workflow efficiency

AI-enabled automation and 3D visualization are reshaping purchasing decisions in the ultrasound devices market by addressing two persistent operational constraints: operator dependency and throughput pressure. Automated measurements, smarter image optimization, and decision-support features reduce scan variability and shorten exam time, which is particularly valuable in high-volume radiology, obstetrics, cardiology, and general imaging settings. At the same time, 3D ultrasound improves anatomical visualization and documentation, supporting broader clinical confidence and influencing market adoption among providers seeking systems that can raise productivity without compromising diagnostic quality.

Rising adoption of portable and wireless ultrasound devices expanding point-of-care diagnostics accessibility

Demand is shifting toward compact and wireless systems as care delivery moves closer to the bedside, ambulatory settings, and remote locations where immediate imaging can change triage and treatment decisions. This is increasing market penetration in the ultrasound devices market by enabling physicians, emergency teams, and primary care providers to use imaging in real time without relying on centralized imaging departments. The practical effect is a broader buyer base that includes smaller clinics, urgent care centers, and decentralized care networks, while established hospitals add portable units to improve responsiveness in intensive care, anesthesia, and emergency medicine workflows.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Increasing chronic disease burden driving demand for non-invasive diagnostic ultrasound imaging systems	2.00%	Moderate	North America, Asia Pacific	High	Near Term
Advancements in AI-enabled and 3D ultrasound technologies enhancing imaging workflow efficiency	1.70%	Moderate	North America, Europe	High	Mid Term
Rising adoption of portable and wireless ultrasound devices expanding point-of-care diagnostics accessibility	1.40%	Moderate	Asia Pacific, Latin America	Emerging	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the largest regional share of the ultrasound devices market in 2025, supported by its mature diagnostic imaging infrastructure, broad availability of advanced ultrasound systems across hospitals and outpatient settings, and steady replacement demand for higher-performance platforms. The region’s leadership is aided by routine use of ultrasound across multiple clinical applications, including radiology, cardiology, obstetrics, and point-of-care settings, which sustains purchasing activity not only for full-size systems but also for portable configurations used in everyday clinical workflows.

Asia Pacific is projected to expand at a 5.02% CAGR over the forecast period, with growth in the ultrasound devices market being fueled by widening access to diagnostic services and increasing equipment adoption across fast-developing healthcare systems. Demand is accelerating as providers add imaging capacity to serve larger patient volumes, while a growing mix of hospitals, clinics, and diagnostic centers creates practical opportunities for both first-time installations and broader use of portable and mid-range systems in routine care delivery.

Key Country Insights

United States

Clinical Imaging Innovation

The U.S. ultrasound devices market is driven by adoption across hospitals, outpatient centers, and specialized care settings. Priorities include advanced imaging capabilities, portable systems, and improved diagnostic workflows that support broader clinical applications and efficient patient management.

Japan

Aging Care Diagnostics

Japan is expanding ultrasound device utilization across hospitals, clinics, and elderly care applications. The market is influenced by demand for non-invasive diagnostic tools, compact imaging systems, and technologies that support efficient healthcare delivery for diverse patient needs.

South Korea

Digital Imaging Adoption

South Korea is adopting ultrasound devices alongside digital healthcare initiatives and advanced diagnostic practices. Market priorities include high-resolution imaging, compact equipment formats, and solutions that improve workflow efficiency in hospitals and specialty medical facilities.

Germany

Healthcare Technology Integration

Germany is integrating ultrasound devices into hospitals and diagnostic facilities with emphasis on precision imaging and efficient care delivery. Market demand is supported by investments in advanced medical equipment and the use of ultrasound across multiple clinical specialties.

France

Diagnostic Care Enhancement

France is utilizing ultrasound devices across hospital departments, outpatient diagnostics, and specialized medical practices. Market development is supported by demand for reliable imaging solutions, improved clinical decision support, and technologies that enable efficient examination procedures.

Italy

Specialty Imaging Utilization

Italy is applying ultrasound devices across diagnostic centers, hospitals, and specialty care areas such as cardiology and obstetrics. Adoption is shaped by the need for versatile imaging platforms, improved diagnostic accuracy, and accessible clinical examination capabilities.

Segment Leadership and Growth Trends

  Product Segment Analysis: Diagnostic Ultrasound Devices (Largest Segment) vs Therapeutic Ultrasound Devices (Fastest-Growing Segment)

Diagnostic Ultrasound Devices held the strongest position in the ultrasound devices market in 2025, accounting for an 80.06% share. This leadership is underpinned by their central role in routine imaging across obstetrics, cardiology, abdominal assessment, and point-of-care evaluation, where non-invasive, real-time visualization is essential to everyday clinical workflows. Demand remains anchored in the broad applicability of diagnostic systems across care settings, making them the core equipment category for providers that rely on ultrasound as a first-line imaging tool.

Therapeutic Ultrasound Devices are emerging as the fastest-growing segment in the ultrasound devices market as clinical use expands beyond imaging into targeted treatment applications. Their momentum is being supported by growing interest in less invasive treatment approaches that can be integrated into modern care pathways with greater procedural precision and reduced reliance on more intensive interventions. Compared with diagnostic systems, this segment is gaining growth traction from a lower installed base and a more expanding use case profile, which creates stronger room for adoption acceleration.

End-use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)

Hospitals represented the largest position in the ultrasound devices market in 2025 with a 42.88% share, and they also continue to register the fastest growth within end use. Their leadership is closely tied to the concentration of imaging volume, emergency care, surgical support, and multi-specialty diagnostic services within hospital environments, where ultrasound systems are used across a wide range of departments and patient acuity levels. The same operating conditions support ongoing growth in the ultrasound devices market, as hospitals continue to absorb rising diagnostic demand while expanding point-of-care and procedural ultrasound use within integrated clinical workflows.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Product	Diagnostic Ultrasound Devices, Therapeutic Ultrasound Devices	Diagnostic Ultrasound Devices	Therapeutic Ultrasound Devices
End-use	Hospitals, Imaging Centres, Research Centres	Hospitals	Hospitals
Portability	Handheld, Compact, Cart/Trolley	Cart/Trolley	Handheld
Application	Cardiology, Obstetrics/Gynaecology, Radiology, Orthopaedic, Anaesthesia, Emergency Medicine, Primary Care, Critical Care	Radiology	Obstetrics/Gynaecology

Competitive Landscape and Market Positioning

Key companies in the ultrasound devices market:

1. GE HealthCare Technologies Inc. (United States)

2. Koninklijke Philips N.V. (Netherlands)

3. Siemens Healthineers AG (Germany)

4. Canon Medical Systems Corporation (Japan)

5. Samsung Medison Co. Ltd. (South Korea)

6. Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China)

7. FUJIFILM SonoSite Inc. (United States)

8. Esaote S.p.A. (Italy)

9. Konica Minolta Inc. (Japan)

10. Hitachi Ltd. (Japan)

Advancements in imaging clarity and portability are driving strong innovation in the ultrasound devices market. Enhanced diagnostic capabilities are improving clinical decision-making across multiple specialties. Continuous technological refinement is strengthening medical imaging performance within the ultrasound devices market.

Industry Development/News

Company Name	Date	Key Development
Samsung Medison	May-25	Samsung Medison acquired French AI startup Sonio for $92 million to integrate advanced artificial intelligence into its ultrasound imaging portfolio. This strategic acquisition enhances the company's diagnostic capabilities and reinforces its competitive positioning in the high-growth AI-enabled medical imaging sector by providing sophisticated workflow and image analysis solutions for clinical practitioners.
GE HealthCare	Jul-24	GE HealthCare agreed to acquire the clinical artificial intelligence business of Intelligent Ultrasound Group PLC. This transaction is designed to bolster GE's ultrasound portfolio with specialized AI-driven software, aiming to streamline diagnostic workflows and strengthen the company's technological footprint in advanced clinical imaging applications through enhanced automation and image interpretation tools.
IMMA Health	Sep-25	IMMA Health secured $2.5 million in funding to accelerate the development and commercialization of its at-home ultrasound platform tailored for IVF patients. By integrating robotics and artificial intelligence, the company aims to decentralize fertility monitoring, offering a new care delivery model that reduces patient clinic visits and increases accessibility for assisted reproductive technology treatments.
Butterfly Network	Mar-26	Butterfly Network received FDA clearance for its AI-powered gestational age estimation tool. The technology utilizes "blind-sweep" capabilities to determine fetal age in under two minutes without requiring expert interpretation. This innovation represents a significant shift in prenatal diagnostic accessibility, particularly for low-resource environments, by reducing the dependency on specialized ultrasound training for critical obstetric assessments.
Conavi Medical	Apr-26	Conavi Medical obtained FDA 510(k) clearance for its next-generation intravascular ultrasound (IVUS) platform. The system is engineered to provide a comprehensive assessment of coronary anatomy within a streamlined single-workflow procedure. This development enhances cardiovascular imaging precision, providing clinicians with improved diagnostic and treatment planning capabilities through high-fidelity visualization and operational efficiency improvements in the interventional cardiology space.
Clarius Mobile Health	Dec-25	Clarius Mobile Health expanded its AI-enabled software ecosystem with new FDA-cleared models, including automated prostate analysis tools. By introducing these features into its ultrasound application, the company aims to improve workflow efficiency and diagnostic accuracy at the point-of-care, reflecting a broader industry trend toward integrating automated measurement capabilities into portable imaging systems for specialized clinical use.
Butterfly Network	Aug-25	Butterfly Network integrated DESKi’s FDA-cleared HeartFocus software into its handheld ultrasound platform. This partnership expands the company's AI-assisted cardiac imaging capabilities, enabling a wider range of healthcare professionals to perform diagnostic-quality heart examinations. The integration emphasizes the strategic importance of third-party software partnerships in increasing the clinical utility and versatility of handheld imaging devices.